Seaport Therapeutics, Inc. - Common Stock (SPTX)
Price History
May 3, 2026 — Aug 18, 2026Investment Snapshot
- P/B of 2.75 — trading above book value
- Piotroski F-Score 0/9 — signs of financial weakness
- Loss-making — negative ROE of -27.5%
Seaport Therapeutics, Inc. - Common Stock (SPTX) is a publicly traded company, listed on the NASDAQ , with a market capitalisation of $1.2 billion . Key value metrics: P/B ratio 2.75, Piotroski F-Score 0 out of 9 .
Value Score
Key Metrics
Seaport Therapeutics, Inc. - Common Stock — Fundamental Analysis Summary
On financial health, SPTX shows a weak Piotroski F-Score of 0/9, a signal of deteriorating financial health, and negative return on equity of -27.5%.
StockPik's composite Value Score for SPTX is 40/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.